About me
Matt Renda has 13 years of academic research experience focused on gene therapy and 17 years of pharmaceutical development experience providing regulatory submission management and medical writing leadership to optimize cross-functional processes, implement innovative technologies, and efficiently develop clinical documents. Matt joined Alexion in 2016 and leads a team focused on evaluating and implementing new technologies for Medical Writing. He received Gold accreditation for completing the AstraZeneca Generative AI Accreditation Programme. Matt holds a PhD in Biochemistry and MS in Microbiology & Immunology from the University of Rochester and conducted postdoctoral research at the Yale Stem Cell Center.
